Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder

Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder

Abstract There are currently five programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors approved for the treatment of locally advanced or metastatic urothelial carcinoma (UC) of the bladder. For platinum-ineligible patients, testing of tumor specimens for PD-L1 expression is require...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgi Tosev, Wasilijiang Wahafu, Philipp Reimold, Ivan Damgov, Constantin Schwab, Cem Aksoy, Adam Kaczorowski, Albrecht Stenzinger, Joanne Nyarangi-Dix, Markus Hohenfellner, Stefan Duensing
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/e0963328ed3e40d1b1cbaada103b02e7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items